Opticyte
PrivateLast Round
Convertible Debt
Dec 5, 2024
Total Funding Raised
$5.7M
Company Overview
Opticyte operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Seed round in November 2020.
Opticyte is a medical device company that develops noninvasive technology for real-time monitoring of cellular oxygenation to aid in the early detection and prevention of organ failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Opticyte Comparables
Compare Opticyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ViOptix, Inc. | 87% | |
| Spectros Medical Devices | 87% | |
| Envello Medical | 84% |
For institutional investors. Book with your work email.
Opticyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Dec 5, 2024 | ||||
| Crowdfunding | Oct 31, 2024 | ||||
| Seed | Nov 1, 2020 | ||||
| Grant | May 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Opticyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| FBomb Angels | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 92% MoM.
- Apr 17, 2026
Monthly visitors increased 33% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
Opticyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Opticyte's valuation, stock price, and market status.
Is Opticyte a public or private company?
Opticyte is a private company.
What is the current stock price of Opticyte?
Opticyte is a private company, so its shares have no public market price. Caplight tracks Opticyte's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Opticyte worth (valuation)?
Valuation information for Opticyte is not publicly available.
Can I buy Opticyte stock?
Opticyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Opticyte's last funding round?
Opticyte's most recent funding round was Convertible Debt on December 5, 2024.
Who are the main investors in Opticyte?
Key investors in Opticyte include NIH RADx, FBomb Angels.
Will Opticyte IPO soon?
No public IPO plans have been announced for Opticyte.
How can I track Opticyte secondary market activity?
Caplight tracks bids, offers, and trades in Opticyte's shares on secondary markets.